- Home
- MRSN vs CVU Comparison
MRSN vs CVU Comparison
Compare MRSN & CVU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRSN
- CVU
- Stock Information
- Founded
- MRSN 2001
- CVU 1980
- Country
- MRSN United States
- CVU United States
- Employees
- MRSN N/A
- CVU N/A
- Industry
- MRSN Biotechnology: Pharmaceutical Preparations
- CVU Military/Government/Technical
- Sector
- MRSN Health Care
- CVU Industrials
- Exchange
- MRSN Nasdaq
- CVU Nasdaq
- Market Cap
- MRSN 71.9M
- CVU 70.2M
- IPO Year
- MRSN 2017
- CVU N/A
- Fundamental
- Price
- MRSN $0.48
- CVU $3.41
- Analyst Decision
- MRSN Buy
- CVU
- Analyst Count
- MRSN 4
- CVU 0
- Target Price
- MRSN $4.33
- CVU N/A
- AVG Volume (30 Days)
- MRSN 3.8M
- CVU 52.3K
- Earning Date
- MRSN 03-03-2025
- CVU 04-04-2025
- Dividend Yield
- MRSN N/A
- CVU N/A
- EPS Growth
- MRSN N/A
- CVU 86.98
- EPS
- MRSN N/A
- CVU 1.37
- Revenue
- MRSN $40,497,000.00
- CVU $82,814,085.00
- Revenue This Year
- MRSN N/A
- CVU N/A
- Revenue Next Year
- MRSN $67.68
- CVU N/A
- P/E Ratio
- MRSN N/A
- CVU $2.52
- Revenue Growth
- MRSN 9.88
- CVU N/A
- 52 Week Low
- MRSN $0.45
- CVU $2.16
- 52 Week High
- MRSN $5.96
- CVU $5.85
- Technical
- Relative Strength Index (RSI)
- MRSN 35.88
- CVU 29.12
- Support Level
- MRSN $0.49
- CVU $3.39
- Resistance Level
- MRSN $0.56
- CVU $3.73
- Average True Range (ATR)
- MRSN 0.05
- CVU 0.23
- MACD
- MRSN 0.02
- CVU -0.03
- Stochastic Oscillator
- MRSN 28.11
- CVU 11.22
About MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company using its differentiated and proprietary ADC platforms to develop targeted drugs with increased tolerability and expanded opportunities to deliver meaningful clinical benefits to patients. The Company's early stage programs includes XMT-1660, a Dolasynthen ADC targeting B7-H4, as well as XMT-2056, a STING agonist ADC developed using the Company's Immunosynthen platform and targeting a novel epitope of human epidermal growth factor receptor 2. The Company also has two earlier stage preclinical candidates, XMT-2068 and XMT-2175, both of which leverage the Company's Immunosynthen platform and target tumor-associated antigens.
About CVU CPI Aerostructures Inc.
CPI Aerostructures Inc is engaged in the manufacturing of structural aircraft parts for fixed-wing aircraft and helicopters in both the commercial and defense markets in the United States. It also provides engineering, program management, supply chain management and kitting, and Maintenance Repair and Overhaul (MRO) services. CPI also acts as a subcontractor to prime aircraft manufacturers in the production of commercial aircraft parts. CPI Aero supplies the E-2D Advanced Hawkeye surveillance aircraft, the A-10 Thunderbolt attack jet, the Gulfstream G650, the UH-60 BLACK HAWK helicopter, and the S-92 helicopter and others.